How should I transition from linaclotide (Linzess) to naloxegol (Movantik)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Linzess to Movantik: Direct Transition Approach

You should stop Linzess (linaclotide) and start Movantik (naloxegol) immediately without any washout period or overlap, as these medications have completely different mechanisms of action and indications.

Critical Context: These Are Different Medications for Different Conditions

The most important consideration is understanding why you're switching, as these drugs treat fundamentally different types of constipation:

  • Linzess (linaclotide): A guanylate cyclase-C agonist FDA-approved for chronic idiopathic constipation (CIC) and IBS-C 1. It works by increasing intestinal fluid secretion and accelerating GI transit 1.

  • Movantik (naloxegol): A peripherally-acting mu-opioid receptor antagonist (PAMORA) FDA-approved specifically for opioid-induced constipation in adults with chronic non-cancer pain 2. It blocks opioid receptors in the gut without affecting central pain relief 3, 4.

The Switching Algorithm

Step 1: Confirm You're on Chronic Opioid Therapy

Movantik should ONLY be used if you are taking opioid pain medications. 2

  • If you're NOT on opioids: Do not switch to Movantik—it won't work and isn't indicated
  • If you ARE on opioids: Proceed with the switch, as Movantik specifically targets opioid-induced constipation 3

Step 2: Stop Linzess Immediately

  • Discontinue Linzess on the day you plan to start Movantik
  • No tapering is required—linaclotide has minimal systemic absorption and a half-life of 6-11 hours 1
  • The drug will be effectively cleared within 24-48 hours

Step 3: Stop Other Laxatives Before Starting Movantik

Per FDA labeling: "Stop taking other laxatives before you start treatment with MOVANTIK" 2

This includes:

  • Any osmotic laxatives (polyethylene glycol, lactulose, magnesium hydroxide)
  • Stimulant laxatives (bisacodyl, senna)
  • Stool softeners

Step 4: Start Movantik the Next Day

Dosing per FDA label 2:

  • Standard dose: 25 mg once daily on an empty stomach
  • Reduced dose: 12.5 mg once daily if you have renal impairment (moderate, severe, or ESRD not on dialysis)
  • Timing: Take at least 1 hour before first meal OR 2 hours after a meal
  • Avoid: Grapefruit and grapefruit juice during treatment

Step 5: Monitor Response and Adjust

  • If Movantik doesn't work after 3 days: Your healthcare provider may add back other laxatives 2
  • If you stop taking opioids: You must also stop Movantik, as it only works for opioid-induced constipation 2

Critical Safety Considerations

Contraindications for Movantik 2:

  • Known or suspected bowel obstruction
  • History of bowel obstruction
  • Allergy to naloxegol

Important Drug Interactions:

Strong CYP3A4 inhibitors (increase naloxegol levels—avoid or use 12.5 mg dose):

  • Clarithromycin, ketoconazole, itraconazole

Strong CYP3A4 inducers (decrease naloxegol levels—avoid):

  • Rifampin, carbamazepine, St. John's Wort

Other opioid antagonists: Avoid concurrent use with other PAMORAs to prevent opioid withdrawal 2

Warning Signs Requiring Immediate Medical Attention:

  • Severe, persistent, or worsening abdominal pain
  • Severe diarrhea (most common side effect, occurring in ~10% of patients) 5
  • Signs of opioid withdrawal: sweating, chills, anxiety, irritability 2

Expected Outcomes

Based on clinical trial data 5:

  • Response rate: 44-48% of patients achieve ≥3 spontaneous bowel movements per week with naloxegol 25 mg
  • Time to first bowel movement: Median ~18-24 hours after first dose
  • Pain control: Should remain unchanged—naloxegol doesn't cross the blood-brain barrier 2

Common Pitfall to Avoid

The biggest mistake is using Movantik for non-opioid-related constipation. If your constipation isn't caused by opioid medications, Movantik will be ineffective and unnecessarily expensive. In that case, continuing Linzess or trying other secretagogues (plecanatide, lubiprostone) would be more appropriate 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.